Q 1. Paget-Schroetter syndrome relates to

Q 2. urokinase derived from

Q 3. true regarding streptokinase

Q 4. initial treatment with warfarin is supported by concomitant administration of which of the following

Q 5. warfarin induced skin necrosis occurs in which week of therapy

Q 6. following is direct fibrinolytic agent

Q 7. risk of intracranial hemorrhage with use of thrombolytic agents is increased in all except

Q 8. recombinant derivative of recombinant tissue type plasminogen activator (rt-PA) is

Q 9. warfarin embryopathy is due to effect of warfarin on which bone matrix protein

Q 10. warfarin induced skin necrosis is seen in patients with congenital or acquired deficiencies of

Q 11. bolus fibrinolytic agent includes

Q 12. half life of t-PA (tissue plasminogen activator) is

Q 13. true regarding streptokinase

Q 14. true statement regarding warfarin

Q 15. oral anticoagulants include

Q 16. fibrin specific plasminogen activators include

Q 17. streptokinase binds to which of the following

Q 18. Purple Toe syndrome is seen in patients receiving warfarin with

Q 19. patients on warfarin with serious bleeding are treated with

Q 20. risk of warfarin embryopathy is greatest in which trimester of pregnancy

Q 21. for prevention or treatment of thrombosis in pregnancy following can be given during pregnancy

Q 22. half life of urokinase is